Concepedia

C. Alvero

CA

3

Publications

137

Citations

3

H-Index

2007

Active since

Affiliations

Harvard University(Current)

Jacobi Medical Center

National Institutes of Health

Merck & Co., Inc., Rahway, NJ, USA (United States)

Eunice Kennedy Shriver National Institute of Child Health and Human Development

C. Alvero is an author at Harvard University.

Publications per year

2007–2015

3

Publications

3

Pharmacokinetics, Safety, and 48-Week Efficacy of Oral Raltegravir in HIV-1-Infected Children Aged 2 Through 18 Years

Sharon Nachman, Naiyu Zheng, Edward P. Acosta et al. · Clinical Infectious Diseases · 2013 · 59 citations · Full text

Pharmacokinetics and Pharmacodynamics of Efavirenz and Nelfinavir in HIV-infected Children Participating in an Area-under-the-curve Controlled Trial

RC Brundage, T Fenton, C. Alvero et al. · Clinical Pharmacology & Therapeutics · 2007 · 45 citations · Full text

Pharmacokinetics and 48-Week Safety and Efficacy of Raltegravir for Oral Suspension in Human Immunodeficiency Virus Type-1-Infected Children 4 Weeks to 2 Years of Age

Sharon Nachman, C. Alvero, Edward P. Acosta et al. · Journal of the Pediatric Infectious Diseases Society · 2015 · 33 citations · Full text

Rows per page

1–3 of 3